CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 53 enrolled
Drug / intervention
drug conditiondrug
Likely dose
drug condition 15mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00842985
NCT00842985Early Ph 1Completed
CompareCT.gov

Dronabinol Interactions in Humans

Yale University·interventional·Posted Feb 12, 2009·Updated May 30, 2017

In Brief

A Early Phase 1 clinical trial evaluating drug condition for Cannabis and Marijuana Abuse. Completed, enrolled 53 participants across 1 site.

Detailed Summary

Marijuana use is a major problem among veterans and non-veterans. A patient's use of marijuana while engaged in psychotherapy treatment may affect their memory and, therefore, limit their ability to benefit from treatment. This study is designed to test a new pharmacotherapy, modafinil, which has the potential to improve memory functioning in marijuana using individuals. We hypothesize that modafinil treatment will decrease ratings of drug liking and improve cognitive measures, especially episodic memory.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCannabis, Marijuana Abuse
CountriesUnited States
CollaboratorsVA Office of Research and Development, National Institute on Drug Abuse (NIDA)

Timeline

Early Ph 1CompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedFeb 12, 2009
Enrollment StartSep 1, 2008
Primary CompletionOct 1, 2009
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 17.4 years ago

Interventions

drug conditiondrug

Dronabinol (15mg) or Modafinil (400mg) or Dronabinol + Modafanil or placebo